The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy
Open accessAbstract
Alzheimer's disease and progressive supranuclear palsy (PSP) represent neurodegenerative tauopathies with predominantly cortical versus subcortical disease burden. In Alzheimer's disease, neuropathology and atrophy preferentially affect 'hub' brain regions that are densely connected. It was unclear whether hubs are differentially affected by neurodegeneration because they are more likely to receive pathological proteins that propagate trans-neuronally, in a prion-like manner, or whether they are selectively vulnerable due to a lack of local trophic factors, higher metabolic demands, or differential gene expression. We assessed the relationship between tau burden and brain functional connectivity, by combining in vivo PET imaging using the ligand AV-1451, and graph theoretic measures of resting state functional MRI in 17 patients with Alzheimer's disease, 17 patients with PSP, and 12 controls. Strongly connected nodes displayed more tau pathology in Alzheimer's disease, independently of intrinsic connectivity network, validating the predictions of theories of trans-neuronal spread but not supporting a role for metabolic demands or deficient trophic support in tau accumulation. This was not a compensatory phenomenon, as the functional consequence of increasing tau burden in Alzheimer's disease was a progressive weakening of the connectivity of these same nodes, reducing weighted degree and local efficiency and resulting in weaker 'small-world' properties. Conversely, in PSP, unlike in Alzheimer's disease, those nodes that accrued pathological tau were those that displayed graph metric properties associated with increased metabolic demand and a lack of trophic support rather than strong functional connectivity. Together, these findings go some way towards explaining why Alzheimer's disease affects large scale connectivity networks throughout cortex while neuropathology in PSP is concentrated in a small number of subcortical structures. Further, we demonstrate that in PSP increasing tau burden in midbrain and deep nuclei was associated with strengthened cortico-cortical functional connectivity. Disrupted cortico-subcortical and cortico-brainstem interactions meant that information transfer took less direct paths, passing through a larger number of cortical nodes, reducing closeness centrality and eigenvector centrality in PSP, while increasing weighted degree, clustering, betweenness centrality and local efficiency. Our results have wide-ranging implications, from the validation of models of tau trafficking in humans to understanding the relationship between regional tau burden and brain functional reorganization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“In Alzheimer’s disease, these pathological proteins arise early in the transentorhinal cortex, from where they spread to limbic regions, followed by inferior frontal and parietal cortex (Braak and Braak, 1991, 1995).”
BackgroundAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
A fast diffeomorphic image registration algorithm
Ashburner, J. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.07.007 · Cited by 8,122
Power, J. D., Barnes, K. A., Snyder, A. Z., Schlaggar, B. L., & Petersen, S. E. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.10.018 · Cited by 7,429
Functional connectivity in the resting brain: a network analysis of the default mode hypothesis
Greicius, M. D., Krasnow, B., Reiss, A. L., & Menon, V. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0135058100 · Cited by 6,358 · cited 4×
“Therefore, one concern might be that correlations between 18F-AV-1451 and degree are driven by the coincidence that Alzheimer’s disease happens to affect the default mode network (DMN), which happens to be a large intrinsic connectivity network.”
BackgroundInfluentialCorrespondence of the brain's functional architecture during activation and rest
Smith, S. M., Fox, P. T., Miller, K. L., Glahn, D. C., Fox, P. M., Mackay, C. E., Filippini, N., Watkins, K. E., Toro, R., Laird, A. R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905267106 · Cited by 5,150
Conn : A Functional Connectivity Toolbox for Correlated and Anticorrelated Brain Networks
Whitfield-Gabrieli, S., & Nieto-Castanon, A. (2012) · Brain Connectivity · doi:10.1089/brain.2012.0073 · Cited by 4,885
Greicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684 · cited 2×
“, 2003), which has been implicated in Alzheimer’s disease (Greicius et al., 2004).”
BackgroundBuckner, R. L., Sepulcre, J., Talukdar, T., Krienen, F. M., Liu, H., Hedden, T., Andrews-Hanna, J. R., Sperling, R. A., & Johnson, K. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5062-08.2009 · Cited by 2,862
Research works printed but not linked: 54
- Abdelnour, 2014, Network diffusion accurately models the relationship between structural and functional brain connectivity networks, Neuroimage, 90, 335, 10.1016/j.neuroimage.2013.12.039 · DOI · Paper page
- Ahmed, 2014, A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity, Acta Neuropathol, 127, 667, 10.1007/s00401-014-1254-6 · DOI · Paper page
- Albert, 1974, The ‘subcortical dementia’ of progressive supranuclear palsy, J Neurol Neurosurg Psychiatry, 37, 121, 10.1136/jnnp.37.2.121 · DOI · Paper page
- Appel, 1981, A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease, Ann Neurol, 10, 499, 10.1002/ana.410100602 · DOI · Paper page
- Baker, 1994, Induction of β (A4)-amyloid in primates by injection of Alzheimer’s disease brain homogenate, Mol Neurobiol, 8, 25, 10.1007/BF02778005 · DOI
- Bevan-Jones, 2017, [18F], J Neurol Neurosurg Psychiatry
- Bevan-Jones, 2017, Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses, BMJ Open, 7, e013187, 10.1136/bmjopen-2016-013187 · DOI
- Braak, 1995, Staging of Alzheimer's disease-related neurofibrillary changes, Neurobiol Aging, 16, 271, 10.1016/0197-4580(95)00021-6 · DOI · Paper page
- Braak, 2013, Amyotrophic lateral sclerosis—a model of corticofugal axonal spread, Nat Rev Neurol, 9, 708, 10.1038/nrneurol.2013.221 · DOI · Paper page
- Chennu, 2017, Brain networks predict metabolism, diagnosis and prognosis at the bedside in disorders of consciousness, Brain, 140, 2120, 10.1093/brain/awx163 · DOI · Paper page
- Clavaguera, 2013, Brain homogenates from human tauopathies induce tau inclusions in mouse brain, Proc Natl Acad Sci USA, 110, 9535, 10.1073/pnas.1301175110 · DOI · Paper page
- Cordato, 2005, Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy, Brain, 128, 1259, 10.1093/brain/awh508 · DOI
- Cordato, 2002, Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy, Brain, 125, 789, 10.1093/brain/awf082 · DOI
- D'Antona, 1985, Subcortical dementia, Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain, 108 (Pt 3), 785
- Dai, 2014, Identifying and mapping connectivity patterns of brain network hubs in Alzheimer's disease, Cereb Cortex
- de Haan, 2012, Activity dependent degeneration explains hub vulnerability in Alzheimer's disease, PLoS Comput Biol, 8, e1002582, 10.1371/journal.pcbi.1002582 · DOI · Paper page
- Durrett, 2010, Some features of the spread of epidemics and information on a random graph, Proc Natl Acad Sci USA, 107, 4491, 10.1073/pnas.0914402107 · DOI
- Ellison, 2012, Neuropathology: a reference text of CNS pathology
- Falcon, 2015, Conformation determines the seeding potencies of native and recombinant Tau aggregates, J Biol Chem, 290, 1049, 10.1074/jbc.M114.589309 · DOI · Paper page
- Foster, 1988, Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography, Ann Neurol, 24, 399, 10.1002/ana.410240308 · DOI · Paper page
- Gardner, 2013, Intrinsic connectivity network disruption in progressive supranuclear palsy, Ann Neurol, 73, 603, 10.1002/ana.23844 · DOI
- Goedert, 2015, Alzheimer’s and Parkinson’s diseases: the prion concept in relation to assembled Aβ, tau, and α-synuclein, Science, 349, 1255555, 10.1126/science.1255555 · DOI · Paper page
- Goedert, 2006, A century of Alzheimer's disease, Science, 314, 777, 10.1126/science.1132814 · DOI · Paper page
- Golbe, 2007, A clinical rating scale for progressive supranuclear palsy, Brain, 130, 1552, 10.1093/brain/awm032 · DOI · Paper page
- Granovetter, 1983, The strength of weak ties: a network theory revisited, Soc Theory, 201, 10.2307/202051 · DOI · Paper page
- Guo, 2014, Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases, Nat Med, 20, 130, 10.1038/nm.3457 · DOI · Paper page
- Höglinger, 2017, Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society Criteria, Mov Disord, 32, 853, 10.1002/mds.26987 · DOI · Paper page
- Ittner, 2011, Amyloid-[beta] and tau–a toxic pas de deux in Alzheimer's disease, Nat Rev Neurosci, 12, 65, 10.1038/nrn2967 · DOI · Paper page
- Jones, 2015, Cascading network failure across the Alzheimer’s disease spectrum, Brain, 139, 547, 10.1093/brain/awv338 · DOI · Paper page
- Joyce, 2010, A new measure of centrality for brain networks, PLoS One, 5, e12200, 10.1371/journal.pone.0012200 · DOI · Paper page
- Klunk, 2004, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B, Ann Neurol, 55, 306, 10.1002/ana.20009 · DOI · Paper page
- Kundu, 2012, Differentiating BOLD and non-BOLD signals in fMRI time series using multi-echo EPI, Neuroimage, 60, 1759, 10.1016/j.neuroimage.2011.12.028 · DOI · Paper page
- Lehmann, 2013, Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer’s disease, Brain, 136, 844, 10.1093/brain/aws327 · DOI · Paper page
- Liu, 2012, Trans-synaptic spread of tau pathology in vivo, PLoS One, 7, e31302, 10.1371/journal.pone.0031302 · DOI · Paper page
- Liu, 2001, Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy, Ann Neurol, 50, 494, 10.1002/ana.1159 · DOI
- Maestú, 2015, A multicenter study of the early detection of synaptic dysfunction in mild cognitive impairment using magnetoencephalography-derived functional connectivity, Neuroimage Clin, 9, 103, 10.1016/j.nicl.2015.07.011 · DOI
- Mandelli, 2016, Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia, Brain, 139 (Pt 10), 2778, 10.1093/brain/aww195 · DOI · Paper page
- Nonaka, 2010, Seeded aggregation and toxicity of α-synuclein and tau: cellular models of neurodegenerative diseases, J Biol Chem, 285, 34885, 10.1074/jbc.M110.148460 · DOI · Paper page
- Okello, 2009, Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study, Neurology, 73, 754, 10.1212/WNL.0b013e3181b23564 · DOI · Paper page
- Ossenkoppele, 2015, Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy, Ann Neurol, 77, 338, 10.1002/ana.24321 · DOI
- Passamonti, 2017, 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy, Brain, 140, 781
- R Core Team, 2016, R: a language and environment for statistical computing
- Raj, 2012, A network diffusion model of disease progression in dementia, Neuron, 73, 1204, 10.1016/j.neuron.2011.12.040 · DOI · Paper page
- Raj, 2015, Network diffusion model of progression predicts longitudinal patterns of atrophy and metabolism in Alzheimer’s disease, Cell Rep, 10, 359, 10.1016/j.celrep.2014.12.034 · DOI · Paper page
- Rittman, 2016, Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy, Neurobiol Aging, 48, 153, 10.1016/j.neurobiolaging.2016.09.001 · DOI
- Saxena, 2011, Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration, Neuron, 71, 35, 10.1016/j.neuron.2011.06.031 · DOI · Paper page
- Schofield, 2012, The relationship between clinical and pathological variables in Richardson’s syndrome, J Neurol, 259, 482, 10.1007/s00415-011-6205-8 · DOI
- Sisodia, 1990, Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing, Science, 248, 492, 10.1126/science.1691865 · DOI · Paper page
- Stam, 2006, Small-world networks and functional connectivity in Alzheimer's disease, Cereb Cortex, 17, 92, 10.1093/cercor/bhj127 · DOI · Paper page
- Stam, 2014, Modern network science of neurological disorders, Nat Rev Neurosci, 15, 683, 10.1038/nrn3801 · DOI · Paper page
- The Mathworks Inc, 2015, Matlab and statistics and machine learning toolbox. Release 2015b ed
- Williams, 2007, Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome, Brain, 130, 1566, 10.1093/brain/awm104 · DOI · Paper page
- Xia, 2017, Multimodal PET imaging of amyloid and Tau pathology in Alzheimer disease and non–Alzheimer disease dementias, PET Clin, 12, 351, 10.1016/j.cpet.2017.02.005 · DOI
- Ypma, 2016, Statistical analysis of tract-tracing experiments demonstrates a dense, complex cortical network in the mouse, PLoS Comput Biol, 12, e1005104, 10.1371/journal.pcbi.1005104 · DOI
Cited by
Dominy, S. S., Lynch, C., Ermini, F., Benedyk, M., Marczyk, A., Konradi, A., Nguyen, M., Haditsch, U., Raha, D., Griffin, C., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau3333 · Cited by 1,966
Protein transmission in neurodegenerative disease
Peng, C., Trojanowski, J. Q., & Lee, V. M.-Y. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0333-7 · Cited by 625
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
Vogel, J. W., Iturria-Medina, Y., Strandberg, O. T., Smith, R., Levitis, E., Evans, A. C., Hansson, O., Initiative, A. D. N., Weiner, M., Aisen, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15701-2 · Cited by 516
A cross-disorder connectome landscape of brain dysconnectivity
van den Heuvel, M. P., & Sporns, O. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0177-6 · Cited by 462
Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Zheng, Q., & Wang, X. (2025) · Protein & Cell · doi:10.1093/procel/pwae026 · Cited by 410
The complexity of tau in Alzheimer’s disease
Naseri, N. N., Wang, H., Guo, J., Sharma, M., & Luo, W. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.022 · Cited by 373
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
Franzmeier, N., Neitzel, J., Rubinski, A., Smith, R., Strandberg, O., Ossenkoppele, R., Hansson, O., Ewers, M., (ADNI), A. D. N. I., Weiner, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14159-1 · Cited by 333
Challenges and hopes for Alzheimer’s disease
Tatulian, S. A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.016 · Cited by 291
The human connectome in Alzheimer disease — relationship to biomarkers and genetics
Yu, M., Sporns, O., & Saykin, A. J. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00529-1 · Cited by 265
Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review
Gibbons, G. S., Lee, V. M. Y., & Trojanowski, J. Q. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.2505 · Cited by 257
From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy
Colin, M., Dujardin, S., Schraen-Maschke, S., Meno-Tetang, G., Duyckaerts, C., Courade, J.-P., & Buée, L. (2020) · Acta Neuropathologica · doi:10.1007/s00401-019-02087-9 · Cited by 187
The use of neuroimaging techniques in the early and differential diagnosis of dementia
Chouliaras, L., & O’Brien, J. T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02215-8 · Cited by 221
“The disrupted functional connectivity seen in AD has been associated with tau burden and neuroin-fl ammation measured through in vivo PET imaging [81, 82].”
BackgroundSelf-citationCortical tau deposition follows patterns of entorhinal functional connectivity in aging
Adams, J. N., Maass, A., Harrison, T. M., Baker, S. L., & Jagust, W. J. (2019) · eLife · doi:10.7554/elife.49132 · Cited by 160
In vivo rate-determining steps of tau seed accumulation in Alzheimer’s disease
Meisl, G., Hidari, E., Allinson, K., Rittman, T., DeVos, S. L., Sanchez, J. S., Xu, C. K., Duff, K. E., Johnson, K. A., Rowe, J. B., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh1448 · Cited by 127
Self-citationSynaptic Loss in Primary Tauopathies Revealed by [ 11 C ] UCB‐J Positron Emission Tomography
Holland, N., Jones, P. S., Savulich, G., Wiggins, J. K., Hong, Y. T., Fryer, T. D., Manavaki, R., Sephton, S. M., Boros, I., Malpetti, M., et al. (2020) · Movement Disorders · doi:10.1002/mds.28188 · Cited by 93
Self-citationPatir, A., Shih, B., McColl, B. W., & Freeman, T. C. (2019) · Glia · doi:10.1002/glia.23572 · Cited by 90
Tau at the interface between neurodegeneration and neuroinflammation
Didonna, A. (2020) · Genes & Immunity · doi:10.1038/s41435-020-00113-5 · Cited by 82
Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia
Hughes, L. E., Rittman, T., Robbins, T. W., & Rowe, J. B. (2018) · Brain · doi:10.1093/brain/awy176 · Cited by 81
Self-citationApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels
Steward, A., Biel, D., Dewenter, A., Roemer, S., Wagner, F., Dehsarvi, A., Rathore, S., Otero Svaldi, D., Higgins, I., Brendel, M., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.4038 · Cited by 67
Microglial Activation and Connectivity in Alzheimer Disease and Aging
Rauchmann, B., Brendel, M., Franzmeier, N., Trappmann, L., Zaganjori, M., Ersoezlue, E., Morenas‐Rodriguez, E., Guersel, S., Burow, L., Kurz, C., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26465 · Cited by 61
Drzezga, A. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.206300 · Cited by 52
Synaptic Loss in Frontotemporal Dementia Revealed by [ 11 C ] UCB‐J Positron Emission Tomography
Malpetti, M., Jones, P. S., Cope, T. E., Holland, N., Naessens, M., Rouse, M. A., Rittman, T., Savulich, G., Whiteside, D. J., Street, D., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26543 · Cited by 53
Self-citationParanjpe, M. D., Chen, X., Liu, M., Paranjpe, I., Leal, J. P., Wang, R., Pomper, M. G., Wong, D. F., Benzinger, T. L. S., & Zhou, Y. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2019.101795 · Cited by 51
Functional network segregation is associated with attenuated tau spreading in Alzheimer's disease
Steward, A., Biel, D., Brendel, M., Dewenter, A., Roemer, S., Rubinski, A., Luan, Y., Dichgans, M., Ewers, M., Franzmeier, N., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12867 · Cited by 39
“Trans-lational research revealed that the more connected a brain region is, the more vulnerable it is to tau pathology 11,12,38 and regions functionally connected to areas harboring tau are more likely to also harbor tau, regardless of spatial proximity.”
Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study
Holland, N., Malpetti, M., Rittman, T., Mak, E. E., Passamonti, L., Kaalund, S. S., Hezemans, F. H., Jones, P. S., Savulich, G., Hong, Y. T., et al. (2022) · Brain · doi:10.1093/brain/awab282 · Cited by 39
Self-citationShaw, A. D., Hughes, L. E., Moran, R., Coyle-Gilchrist, I., Rittman, T., & Rowe, J. B. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhz024 · Cited by 30
Self-citationThe Effects of Amyloid and Tau on Functional Network Connectivity in Older Populations
Wales, R. M., & Leung, H.-C. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0902 · Cited by 26
Atomoxetine and citalopram alter brain network organization in Parkinson’s disease
Borchert, R. J., Rittman, T., Rae, C. L., Passamonti, L., Jones, S. P., Vatansever, D., Vázquez Rodríguez, P., Ye, Z., Nombela, C., Hughes, L. E., et al. (2019) · Brain Communications · doi:10.1093/braincomms/fcz013 · Cited by 14
Self-citationNew Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol
Lanskey, J. H., Kocagoncu, E., Quinn, A. J., Cheng, Y.-J., Karadag, M., Pitt, J., Lowe, S., Perkinton, M., Raymont, V., Singh, K. D., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055135 · Cited by 10
Self-citationStrobel, J., Müller, H.-P., Ludolph, A. C., Beer, A. J., Sollmann, N., & Kassubek, J. (2023) · Cells · doi:10.3390/cells12242776 · Cited by 10
Metadata
- Authors
- Cope, T. E., Rittman, T., Borchert, R. J., Jones, P. S., Vatansever, D., Allinson, K., Passamonti, L., Vazquez Rodriguez, P., Bevan-Jones, W. R., O'Brien, J. T., & Rowe, J. B.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-01-05
- Volume
- 141
- Issue
- 2
- Pages
- 550-567
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2766289228
- Cited by
- 246
- References
- 39
- FWCI
- 12.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- National Institutes of Health
- Wellcome Trust (JBR 103838)
- National Institute for Health Research (RG64473)
- PSP Association
- Medical Research Council (MC-A060-5PQ30)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.